ArticleExperimental biology and medicine (Maywood, N.J.)2023

Febuxostat ameliorates APAP-induced acute liver injury by activating Keap1/Nrf2 and inhibiting TLR4/NF-κB p65 pathways.

Jinhong Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.